Da-Qiang Li

539 total citations
19 papers, 425 citations indexed

About

Da-Qiang Li is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Da-Qiang Li has authored 19 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Da-Qiang Li's work include Histone Deacetylase Inhibitors Research (7 papers), Ubiquitin and proteasome pathways (6 papers) and Protein Degradation and Inhibitors (5 papers). Da-Qiang Li is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Ubiquitin and proteasome pathways (6 papers) and Protein Degradation and Inhibitors (5 papers). Da-Qiang Li collaborates with scholars based in China, United States and Hong Kong. Da-Qiang Li's co-authors include Suresh B. Pakala, Rakesh Kumar, Jeyanthy Eswaran, Sujit S. Nair, Rakesh Kumar, Kazufumi Ohshiro, Sirigiri Divijendra Natha Reddy, Rakesh Kumar, Yongzhou Hu and Xiaowu Dong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Da-Qiang Li

17 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Da-Qiang Li China 11 334 139 45 44 44 19 425
Min‐Wu Chao Taiwan 15 364 1.1× 149 1.1× 31 0.7× 86 2.0× 39 0.9× 26 492
Henrik Moebitz Switzerland 5 325 1.0× 119 0.9× 54 1.2× 105 2.4× 28 0.6× 8 441
Rosemary Burke United Kingdom 13 404 1.2× 112 0.8× 15 0.3× 93 2.1× 71 1.6× 24 579
Kerry A. Pickin United States 9 315 0.9× 187 1.3× 19 0.4× 45 1.0× 31 0.7× 11 456
Chon Lai United States 6 286 0.9× 72 0.5× 41 0.9× 57 1.3× 29 0.7× 10 364
Limin Chen China 14 417 1.2× 77 0.6× 21 0.5× 45 1.0× 154 3.5× 28 548
Takaharu Hirayama Japan 8 186 0.6× 82 0.6× 31 0.7× 115 2.6× 33 0.8× 9 356
Elisabeth V. Schneider Germany 7 238 0.7× 172 1.2× 44 1.0× 37 0.8× 18 0.4× 8 409
Eliana MC Tacconi United Kingdom 6 345 1.0× 76 0.5× 15 0.3× 43 1.0× 28 0.6× 6 417
Laura A. Lopez-Garcia Germany 13 517 1.5× 73 0.5× 25 0.6× 109 2.5× 32 0.7× 16 629

Countries citing papers authored by Da-Qiang Li

Since Specialization
Citations

This map shows the geographic impact of Da-Qiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da-Qiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da-Qiang Li more than expected).

Fields of papers citing papers by Da-Qiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Da-Qiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da-Qiang Li. The network helps show where Da-Qiang Li may publish in the future.

Co-authorship network of co-authors of Da-Qiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Da-Qiang Li. A scholar is included among the top collaborators of Da-Qiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Da-Qiang Li. Da-Qiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Laurent, Paôline, Vidyanath Chaudhary, Da-Qiang Li, et al.. (2025). The immunoproteasome regulates ILC2 responses by modulating mitochondrial capacity. Proceedings of the National Academy of Sciences. 122(47). e2518190122–e2518190122. 1 indexed citations
2.
Du, Yawei, Jiayi Wang, Da-Qiang Li, et al.. (2025). Optimizing type H vessels formation via short fibers 3D scaffolds with maintaining redox homeostasis for osteoporotic bone remodeling. Bioactive Materials. 53. 417–432.
3.
Gao, Yue, Xiaowu Dong, Li Jia, et al.. (2025). Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors. European Journal of Medicinal Chemistry. 296. 117845–117845.
4.
Hsu, Hao-Chi, Da-Qiang Li, Wenhu Zhan, et al.. (2023). Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors. Nature Communications. 14(1). 8302–8302. 10 indexed citations
5.
6.
Zhan, Wenhu, Da-Qiang Li, Rong Wang, et al.. (2023). Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit. Journal of Medicinal Chemistry. 66(2). 1172–1185. 3 indexed citations
7.
Yu, Jianjun, Jieyu Liu, Da-Qiang Li, et al.. (2018). Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitors. European Journal of Medicinal Chemistry. 164. 423–439. 2 indexed citations
8.
Yu, Jianjun, Lei Xu, Jieyu Liu, et al.. (2018). Design, synthesis, and biological evaluation of novel phenol ether derivatives as non-covalent proteasome inhibitors. European Journal of Medicinal Chemistry. 161. 543–558. 8 indexed citations
9.
Xu, Lei, et al.. (2018). Design, synthesis, and molecular docking study of 3H‐imidazole[4,5‐c]pyridine derivatives as CDK2 inhibitors. Archiv der Pharmazie. 351(6). e1700381–e1700381. 8 indexed citations
10.
Li, Da-Qiang, Xiaodong Ma, Lei Xu, et al.. (2018). Development of Macrocyclic Peptides Containing Epoxyketone with Oral Availability as Proteasome Inhibitors. Journal of Medicinal Chemistry. 61(20). 9177–9204. 16 indexed citations
11.
Li, Da-Qiang & Rakesh Kumar. (2015). Unravelling the Complexity and Functions of MTA Coregulators in Human Cancer. Advances in cancer research. 127. 1–47. 27 indexed citations
12.
Zhan, Wenhu, Da-Qiang Li, Jinxin Che, et al.. (2014). Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: Toward the discovery of novel Akt1 inhibitors. European Journal of Medicinal Chemistry. 75. 11–20. 47 indexed citations
13.
14.
Tang, Fengxiang, et al.. (2013). Dissociation Constant and Solubility of (S)-2-Hydroxy-4-phenylbutyric Acid. Journal of Chemical & Engineering Data. 58(5). 1265–1270. 5 indexed citations
15.
Li, Da-Qiang, Suresh B. Pakala, Sujit S. Nair, Jeyanthy Eswaran, & Rakesh Kumar. (2012). Metastasis-Associated Protein 1/Nucleosome Remodeling and Histone Deacetylase Complex in Cancer. Cancer Research. 72(2). 387–394. 96 indexed citations
16.
Li, Da-Qiang & Rakesh Kumar. (2010). Mi-2/NuRD complex making inroads into DNA-damage response pathway. Cell Cycle. 9(11). 2071–2079. 37 indexed citations
17.
Li, Da-Qiang, Suresh B. Pakala, Sirigiri Divijendra Natha Reddy, et al.. (2010). Revelation of p53-independent Function of MTA1 in DNA Damage Response via Modulation of the p21 -Proliferating Cell Nuclear Antigen Pathway. Journal of Biological Chemistry. 285(13). 10044–10052. 48 indexed citations
18.
Li, Da-Qiang, Kazufumi Ohshiro, Sirigiri Divijendra Natha Reddy, et al.. (2009). E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proceedings of the National Academy of Sciences. 106(41). 17493–17498. 72 indexed citations
19.
Li, Da-Qiang. (2004). Effects of mifepristone on proliferation of human gastric adenocarcinoma cell line SGC-7 901in vitro. World Journal of Gastroenterology. 10(18). 2628–2628. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min‐Wu Chao Breakdown of academic impact, for papers by Henrik Moebitz Breakdown of academic impact, for papers by Rosemary Burke Breakdown of academic impact, for papers by Kerry A. Pickin Breakdown of academic impact, for papers by Chon Lai Breakdown of academic impact, for papers by Limin Chen Breakdown of academic impact, for papers by Takaharu Hirayama Breakdown of academic impact, for papers by Elisabeth V. Schneider Breakdown of academic impact, for papers by Eliana MC Tacconi Breakdown of academic impact, for papers by Laura A. Lopez-Garcia
Rankless by CCL
2026